Thursday, June 30 2022 Sign In   |    Register

News Quick Search



Front Page
Power News
Gas News
Today's News
Yesterday's News
Week of Jun 27
Week of Jun 20
Week of Jun 13
Week of Jun 06
Week of May 30
By Topic
By News Partner
News Customization


Pro Plus(+)

Add on products to your professional subscription.
  • Energy Archive News

    Home > News > Gas News > News Article

    Share by Email E-mail Printer Friendly Print

    ADNOC reveals offer price for Borouge IPO as Asia’s richest man invests in Abu Dhabi’s largest listing

    May 24, 2022 - Abdul Rawuf


      The Abu Dhabi National Oil Company (ADNOC), together with its long-standing partner Borealis AG, have revealed the offer price for the initial public offering (IPO) of Borouge plc, their petrochemicals joint venture, on the Abu Dhabi Securities Exchange (ADX).

      The price per share for the offering has been set at AED 2.45, implying an equity value of $20 billion, AED 73.6 billion, making the Borouge IPO the largest-ever listing to date in Abu Dhabi's history.

      The offer price was determined by ADNOC and Borealis - as the selling shareholders - following investor engagement that saw significant strong initial demand indications from both local and international investors ahead of the start of the subscription period.

      Asia's richest billionaire Gautam Adani and Abu Dhabi's ADQ are among seven cornerstone investors, which include International Holding Company, Multiply Group, Alpha Dhabi Holding, Abu Dhabi Pension Fund, and the Emirates Investment Authority.

      The cornerstone investors have, either directly or indirectly, made a combined commitment of approximately $570 million (AED2.1 billion) to the IPO, subject to a minimum six-month lock-up period.

      Borouge IPO subscription

      Abu Dhabi National Oil Co (ADNOC) and Australian chemicals producer Borealis AG plan to sell a 10 percent stake in their petrochemical joint venture in the initial public offering (IPO).

      The IPO subscription period has commenced 23 May, 2022, and will close to retail investors on 28 May, 2022, and to qualified institutional investors on 30 May, 2022.

      The expected date of listing on the ADX is 3 June, 2022.

      Borouge has a robust financial profile, with full-year revenue of $5.5 billion in 2021 and profit for the year of $1.5 billion for its ADP business only, with a very strong cash flow generation record that supports its capacity to pay highly competitive future dividends.

      For 2022, the company expects to pay $975 million in dividends to shareholders. In 2023, Borouge expects to pay no less than $1.3 billion for the full-year period, equivalent to a dividend yield of 6.5 percent based on the price per share announced for the offering.

      The selling shareholders believe the offer price per share provides investors with a highly attractive value proposition that reflects their long-term confidence in Borouge's growth trajectory.

      This decision also reflects ADNOC's prioritisation of a supportive aftermarket performance post-listing and robust dividend policy.

      Through the Borouge IPO, ADNOC is offering investors another highly compelling investment opportunity to invest alongside ADNOC in a company that is set to play a vital role in sustainable growth for Abu Dhabi and the UAE.

      Details on Borouge: The joint venture between ADNOC and Borealis

      Borouge, established in 1998, combines the strength and experience of ADNOC and Borealis, through Borouge ADP, its operations joint venture, headquartered in Abu Dhabi and Borouge PTE, its sales and marketing joint venture, headquartered in Singapore.

      Today, Borouge is one of the world's leading providers of innovative and differentiated polyolefin solutions for the agriculture, infrastructure, energy, advanced packaging, mobility and healthcare industries.

      The company employs over 3,100 people and serves customers in more than 50 countries across Asia, the Middle East and Africa.

      The Borouge portfolio of products comprises polyethylene and polypropylene, the two most common types of polymers, which are used for a variety of applications such as sustainable packaging, pipes and fittings, wires, cables automotive and medical applications.

      Borouge's polymer solutions are categorised in two main product segments: consumer solutions and infrastructure solutions.

      Consumer solutions include sustainable packaging, medical containers and greenhouse films, while infrastructure solutions include water and gas pipes and cables for power transmission.

      Central to Borouge's growth strategy will be the continued growth of its product portfolio through innovation, sustainable solutions, new product development and strategic market and geographic expansion.

      The company will focus on offering its differentiated product offering and industry-leading innovation capabilities to premium pricing end-markets, including access to and use of Borealis' Borstar technology, enabling Borouge to offer tailored solutions for demanding end-use applications integral to everyday life.

      Borouge will also benefit from ADNOC's recent equity investment in Borealis, which further expands ADNOC's long-standing partnership with Borealis while accelerating the delivery of ADNOC's broader Downstream and Industrial growth programme.

      ADNOC is well-positioned to capitalise on growth opportunities in the chemicals and petrochemical sector globally, building on its world-class refining and petrochemicals facilities in Al Ruwais Industrial City, Abu Dhabi.

      ADNOC has already embarked on a major expansion drive in this space, including the recently announced Borouge 4 complex and the TA'ZIZ Industrial Chemicals Zone in Ruwais.

      Through its subsidiaries, Borouge already operates one of the world's largest integrated polyolefins complexes in Ruwais, and has a diverse regional footprint of logistics hubs, warehouses and gateways across the MENA region, Europe, and Asia, as well as a Compounding Manufacturing Plant in Shanghai.

      Over the last six years, ADNOC has actively managed its businesses and capital and successfully developed a more open, flexible and innovative partnership model across its integrated upstream and downstream value chain.

      This value creation and growth strategy is enabled by a $122 billion (AED447.7 billion) capital investment programme across the group between 2021 to 2025.

      Through the listing of minority stakes in select operating businesses, initiated with the successful IPO of ADNOC Distribution in 2017, and subsequent record-setting ADX listings of ADNOC Drilling and Fertiglobe, respectively, in October 2021, ADNOC is broadening its investor base and access to capital, while also supporting the continued growth and expansion of the UAE's private sector and capital markets.

      This approach allows domestic and international investors the opportunity to invest and share in the ownership and growth of ADNOC's world-class energy assets.

      For all the latest business news from the UAE and Gulf countries, follow us on Twitter and Linkedin, like us on Facebook and subscribe to our YouTube page, which is updated daily.


    Other Articles - International


       Home  -  Feedback  -  Contact Us  -  Safe Sender  -  About Energy Central   
    Copyright © 1996-2022 by CyberTech, Inc. All rights reserved.
    Energy Central® and Energy Central Professional® are registered trademarks of CyberTech, Incorporated. Data and information is provided for informational purposes only, and is not intended for trading purposes. CyberTech does not warrant that the information or services of Energy Central will meet any specific requirements; nor will it be error free or uninterrupted; nor shall CyberTech be liable for any indirect, incidental or consequential damages (including lost data, information or profits) sustained or incurred in connection with the use of, operation of, or inability to use Energy Central. Other terms of use may apply. Membership information is confidential and subject to our privacy agreement.